G1 THERAPEUTICS, INC. Accrued Liabilities, Current
G1 THERAPEUTICS, INC. had Accrued Liabilities, Current of $17.08 million as of 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2024-08-08
- 2024-06-30: Accrued Liabilities, Current $17.08M.
- 2024-03-31: Accrued Liabilities, Current $17.87M.
- 2023-12-31: Accrued Liabilities, Current $21.89M.
- 2023-09-30: Accrued Liabilities, Current $24.18M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2024-06-30 | $17.08M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $17.87M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $21.89M 10-Q · filed 2024-08-08 |
| 2023-09-30 | $24.18M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $24.68M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $22.77M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $25.56M 10-K · filed 2024-02-28 |
| 2022-09-30 | $27.25M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $26.60M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $22.58M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $23.18M 10-K · filed 2023-03-01 |
| 2021-09-30 | $22.01M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $18.57M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $18.07M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $16.49M 10-K · filed 2022-02-23 |
| 2020-09-30 | $15.66M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $18.31M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $12.68M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $15.40M 10-K · filed 2021-02-24 |
| 2019-09-30 | $13.51M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $14.23M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $8.11M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $8.98M 10-K · filed 2020-02-26 |
| 2018-09-30 | $10.92M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $10.69M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $8.63M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $7.52M 10-K · filed 2019-02-28 |
| 2017-09-30 | $6.19M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $5.28M 10-Q · filed 2017-08-09 |
| 2016-12-31 | $2.85M 10-K · filed 2018-02-21 |